Quantcast

Reportlinker Adds World Ventricular Assist Devices Market Report

September 10, 2009

NEW YORK, Sept. 10 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue.

World Ventricular Assist Devices Market

http://www.reportlinker.com/p0109889/World-Ventricular-Assist-Devices-Market.html

This report analyzes the worldwide markets for Ventricular Assist Devices in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual forecasts are provided for the period of 2006 through 2015. A five-year historic analysis is also provided for these markets with annual market analytics. The report profiles 28 companies including many key and niche players worldwide such as Abiomed, Inc., Berlin Heart GmbH, EvaHeart Medical USA, Inc., HeartWare Limited, Jarvik Heart, Inc., MEDOS Medizentechnik AG, MicroMed Cardiovascular, Inc., SynCardia Systems, Inc., Terumo Heart, Inc., Thoratec Corporation, Ventracor Limited, and World Heart Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

VENTRICULAR ASSIST DEVICES

A GLOBAL STRATEGIC BUSINESS REPORT MCP-1602

CONTENTS

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. Introduction II-1

Global & Regional Market Analysis II-1

Opportunities in VAD Market II-1

Destination Therapy – An Immense Potential Opportunity II-1

Next Generation Devices to Offer Pronounced Scope II-2

Heart Transplantation Scenario II-2

Table 1: Number of Heart Transplants Worldwide (2000-2006)

(In Units) (includes corresponding Graph/Chart) II-2

Table 2: Heart Transplants Worldwide (2008E): Percentage

Share Breakdown by Country/Region (includes corresponding

Graph/Chart) II-3

2. Competition II-4

Thoratec is the Clear Leader II-4

Leading Players in the Global VAD Market II-4

Table 3: Leading Players in the Global VAD and Circulatory

Support Market (2007): Percentage Breakdown of Value Sales

for Thoratec, Abiomed, WorldHeart and Others (includes

corresponding Graph/Chart) II-4

Table 4: Global VAD Market (2007): Implantations in Units by

Select Player – Thoratec, MicroMed Cardiovascular, Berlin

Heart, Ventracor, Terumo Heart and HeartWare (includes

corresponding Graph/Chart) II-4

Competition Heats Up II-5

Competitive Technologies II-5

3. VAD – An Insight II-6

Heart – The Vital Organ II-6

Heart Diseases II-6

Congenital Heart Disease II-6

Congestive Heart Failure II-6

Mechanical Circulatory Support Systems II-6

Total Artificial Heart II-6

VADs II-7

VADs Usage by Indication and Time Duration II-7

Types II-8

VAD Components II-8

VAD Pumps II-8

Li-Ion Batteries: Reliable Power Sources for Portable

Medical Devices II-9

Implantation Procedure II-9

Aftercare II-9

Complications II-10

Infection II-10

Internal Bleeding II-10

Thrombus II-10

Table 5: Percentage Breakdown of Possible Complications in

VADs Usage by Type – Infection, Bleeding, Arrhythmia,

Renal Dysfunction, Respiratory Dysfunction, Neurologic

Dysfunction, RV Dysfunction and Others (includes

corresponding Graph/Chart) II-10

Pricing of VAD II-11

Table 6: Average Selling Prices of Select VADs by Company

and Model II-11

VAD Improvisations II-11

LVADs – An Introduction II-12

LVAD Milestones II-12

An Effective Therapeutic Device for End-Stage Congestive

Heart Failure II-13

Ventricular Assistance Vs. Heart Replacement II-13

4. An Insight into the First, Second and Third Generation VADs II-15

First Generation VAD II-15

Second Generation VAD II-15

Rotary Axial Flow Pumps II-15

Drawbacks of Axial Flow Pump II-16

Third Generation VAD II-16

Select First, Second and Third Generation Implantable VADs II-17

5. Reimbursement Scenario II-18

Government Regulations II-18

The US II-18

Canada II-18

Europe II-18

6. Product Approvals/Innovations/Introductions II-19

Thoratec Receives FDA Approval for its HeartMate II LVAS II-19

HeartWare Receives Conditional Approval for its HeartWare LVAS II-19

Abiomed Receives CE Mark for AB5000 Portable Driver II-19

Ventracor Receives USFDA Approval to Use its VentrAssist

Device in Clinical Trials II-19

NewCorTec Launches a New LVAD II-20

WorldHeart Launches New Pediatric VAD II-20

Ventracor Obtains FDA Approval for VentrAssist’s US BTT Trial II-20

MicroMed Cardiovascular Obtains 5-Year CE Mark Extension for

DeBakey II-20

Thoratec Submits PMA for HeartMate II Left Ventricular Assist

System II-20

Ventracor Receives ‘Commercial Ready’ Grant to Develop

VentrAssist LVAD II-20

Terumo Heart Obtains CE Mark for its DuraHeart(R) LVAS in Europe II-21

Abiomed Acquires Regulatory Approval in Australia for Impella

LP 2.5 LVAD II-21

Abiomed Receives FDA Approval for Impella 2.5 VAD Pilot Trials II-21

Biophan Develops New MYO-VAD II-21

Queensland University of Technology Invents Counter-Flow Pump II-22

HeartWare Obtains German Regulatory Approval for its HVAD(TM) II-22

Abiomed Receives Regulatory Approval in France for its AB5000 VAD II-22

MiTi Develops MitiHeart LVAD for Heart Failure Patients II-22

MicroMed Cardiovascular’s ‘DeBakey VAD Child’ Receives FDA

Approval II-23

7. Recent Industry Activity II-24

UPMC Wins Gold Seal of Approval(TM) to Use VADs in Destination

Therapy II-24

E-Wilson Acquires 97% of the MicroMed Cardiovascular’s

Outstanding Shares II-24

World Heart Enters into Partnership with Abiomed II-24

Thoratec Corporation Enters into Agreement with Levitronix II-25

World Heart Implants First Rotary VAD II-25

Abiomed Unveils a New Educational as well as Service Program II-25

MicroMed Technology Merges with Salmon Express II-26

Abiomed Acquires Impella CardioSystems II-26

Thoratec Announces 40% Increase in Medicare Refund on VADs

Used in DT II-26

National Heart, Lung and Blood Institute Awards Contract worth

$6.95 Million II-26

8. Focus on Select Global Players II-28

Abiomed, Inc. (USA) II-28

Berlin Heart GmbH (Germany) II-28

EvaHeart Medical USA, Inc. (USA) II-28

HeartWare Limited (Australia) II-28

Jarvik Heart, Inc. (USA) II-28

MEDOS Medizentechnik AG (Germany) II-29

MicroMed Cardiovascular, Inc. (USA) II-29

SynCardia Systems, Inc. (USA) II-29

Terumo Heart, Inc. (USA) II-29

Thoratec Corporation (USA) II-29

Ventracor Limited (Australia) II-30

World Heart Corporation (USA) II-30

9. Global Market Perspective II-31

Table 7: World Recent Past, Current & Future Market Analysis

for Ventricular Assist Devices by Geographic Region – US,

Europe, and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2006 through

2015 (includes corresponding Graph/Chart) II-31

Table 8: World Historic Review for Ventricular Assist Devices

by Geographic Region – US, Europe, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2001 through 2005 (includes corresponding

Graph/Chart) II-31

Table 9: World 10-Year Perspective for Ventricular Assist

Devices by Geographic Region – Percentage Breakdown of Dollar

Sales for US, Europe, and Rest of World Markets for Years

2006, 2009 & 2015 (includes corresponding Graph/Chart) II-32

III. MARKET

1. The United States III-1

A.Market Analysis III-1

Heart Ailments – The Death Sentence III-1

Table 10: Incidence, Prevalence and Deaths due to Heart

Ailments in the US (2007) (includes corresponding

Graph/Chart) III-1

Huge Waiting Time for Heart Transplant III-1

VADs for Heart Failures III-2

Table 11: VAD Market in the US: Percentage Breakdown by

Indication: Bridge-to-Transplant, Destination Therapy,

Bridge-to-Recovery and Others (includes corresponding

Graph/Chart) III-2

Market Dynamics III-2

High Selling Price III-2

Drug Industry Poses Intense Competition III-2

Lack of Timely and Quick FDA Approvals III-3

Reimbursement III-3

CMS Increases LVAD Coverage for Heart Patients III-3

New Facility Criteria to Hospitals on VAD Implantation for

Destination Therapy III-4

Competition III-4

Table 12: Leading Players in the US Bridge-to-Transplant

VAD Market (2008E) – Percentage Breakdown of Sales for

Thoratec and Others III-4

Table 13: Leading Players in the US destination therapy

VAD Market (2007): Percentage Breakdown of Sales for

Thoratec and Others III-5

Product Approvals/Innovations/Introductions III-5

Strategic Corporate Developments III-7

Key Players III-10

B.Market Analytics III-12

Table 14: US Recent Past, Current & Future Analysis for

Ventricular Assist Devices Market Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2006

through 2015 (includes corresponding Graph/Chart) III-12

Table 15: US Historic Review for Ventricular Assist Devices

Market Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2001 through 2005 (includes

corresponding Graph/Chart) III-13

2. Europe III-14

A.Market Analysis III-14

Competitive landscape III-14

Next-generation VADs in Europe by Company (2007) III-14

Table 16: Heart Transplants and Patients Waiting List in

Europe (2005-2007): Figures in Units (includes

corresponding Graph/Chart) III-14

Belgium III-15

Reimbursement Scenario III-15

Key Data III-15

Table 17: Belgium VAD Market (2002-2005): Implants in

Units (includes corresponding Graph/Chart) III-15

Table 18: Belgium VAD Market (2002-2005): BTT Implants in

Units (includes corresponding Graph/Chart) III-15

Table 19: Belgium VAD Market (2004-2005): BTT Implants in

Units by Device – Incor, Excor, Novacor, Thoratec, Medos,

and TCI HM (includes corresponding Graph/Chart) III-16

Germany III-16

The United Kingdom III-16

Product Approvals/Innovations/Introductions III-17

Strategic Corporate Development III-18

Key Players III-18

B.Market Analytics III-19

Table 20: European Recent Past, Current & Future Analysis

for Ventricular Assist Devices Market Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2006

through 2015 (includes corresponding Graph/Chart) III-19

Table 21: European Historic Review for Ventricular Assist

Devices Market Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2001 through 2005 (includes

corresponding Graph/Chart) III-20

3. Rest of World III-21

A.Market Analysis III-21

Product Innovations/Approvals III-21

Strategic Corporate Development III-21

Key Players III-21

B.Market Analytics III-22

Table 22: Rest of World Recent Past, Current & Future

Analysis for Ventricular Assist Devices Market Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2015 (includes corresponding Graph/Chart) III-22

Table 23: Rest of World Historic Review for Ventricular

Assist Devices Market Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2001 through 2005

(includes corresponding Graph/Chart) III-23

IV. COMPETITIVE LANDSCAPE

To order this report:

World Ventricular Assist Devices Market

http://www.reportlinker.com/p0109889/World-Ventricular-Assist-Devices-Market.html

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


Source: newswire



comments powered by Disqus